Genetic Analysis of the Atrial Natriuretic Peptide Gene Polymorphisms among Essential Hypertensive Patients in Malaysia

Table 2

Clinical characteristics of EHT, EHT + T2DM, and control subjects.

Parameter	EHT ()	EHT + T2DM ()	Control ()
AGE	59.45 ± 10.34	59.05 ± 11.10	52.51 ± 9.41
SBP	152.01 ± 23.10	150.51 ± 20.00	122.21 ± 11.24
DBP	94.12 ± 10.00	93.00 ± 9.34	76.20 ± 9.00
BMI	26.21 ± 6.02	28.04 ± 4.25	25.00 ± 4.00
FBS	5.46 ± 1.11	7.89 ± 1.35	5.04 ± 0.50
TCH	5.02 ± 1.10	4.53 ± 1.04	5.10 ± 1.31
LDL	3.01 ± 1.10	3.00 ± 1.00	3.21 ± 1.10
HDL	1.34 ± 0.34	1.21 ± 0.30	1.30 ± 0.52
TG	1.50 ± 0.52	2.00 ± 0.53	1.23 ± 0.55

EHT refers to essential hypertensive patients, EHT + T2DM refers to essential hypertensive patients with Type 2 Diabetes Mellitus, and control refers to healthy subjects. value is obtained by the comparisons of means between EHT and control subjects as well as between EHT + T2DM and control subjects, in the same row significant. Value mean ± standard deviation. Nonsignificant .